1. Home
  2. Products

The t:slim X2 Insulin Pump System

Up to 38% smaller than other insulin pumps1

Compact, watertight, and rechargeable via a micro USB port, the t:slim X2™ insulin pump can integrate with Dexcom G6 continuous glucose monitor­ing (CGM, sold separately). When integrated with CGM, patients can use either Control‑IQ™ technology or Basal-IQ™ technology.

Tandem_Insulin_Pump_Size

A Stand-Alone Insulin Pump

The t:slim X2 insulin pump can be used with or without CGM. When CGM is turned off, the Bolus and Options buttons are placed in the center of the screen for easy access.

Predictive Technology

Optional Control-IQ technology (advanced hybrid close-loop system) helps protect from highs and lows. Basal-IQ technology (predictive low glucose suspend) helps reduce the frequency and duration of low-glucose events.

In-depth Analysis

Uncover meaningful insights and trends to help fine tune therapy using our diabetes web management applications. Data can be viewed and printed from a single, user-friendly webpage.

Control-IQ Advanced Hybrid Closed-Loop Technology

Control-IQ technology uses an algorithm to automatically adjust insulin in response to predicted glucose levels to help increase time in the American Diabetes Association-recommended target glucose range (3.9-10.0 mmol/L).*

View study

Predictive technologies help deliver insulin, making it simpler to manage diabetes

Control-IQ Technology

Control-IQ advanced hybrid closed-loop technology on the t:slim X2 insulin pump is designed to help increase time in range (3.9-10.0 mmol/L)* using Dexcom G6 CGM values to predict glucose levels 30 minutes ahead and adjust insulin delivery accordingly; including delivery of automatic correction boluses as needed.†

Advanced Hybrid Closed Loop

Control-IQ technology adjusts insulin delivery to help prevent highs and lows, while still allowing the user to manually bolus for meals.

Automatic Correction Bolus Delivery

Control-IQ technology on the t:slim X2 pump delivers automatic correction boluses, up to 60% once per hour, to help prevent highs.†

Exercise Activity and Sleep Activity

Dedicated settings for Sleep Activity and Exercise Activity adjust treatment values to better match different needs when activities are enabled.

EXPLORE CONTROL-IQ

Basal-IQ Technology

Basal-IQ technology helps reduce the frequency and duration of low-glucose events by using Dexcom G6 CGM values to predict glucose levels 30 minutes ahead and suspending insulin if they are expected to drop below 4.4 mmol/L, or if a CGM reading falls below 3.9 mmol/L.

Predictive Low Glucose Suspend (PLGS)

PLGS technology is particularly beneficial to patients who don’t always recognize when their glucose level is dropping.

Reduce Lows Without Rebound Highs

In studies, Basal-IQ technology reduced time spent below 10.5 mmol/L by 31% and demonstrated no rebound hyperglycemia.2

Simple Set-up

Basal-IQ technology on the t:slim X2 insulin pump has no complicated settings to manage. It operates in the background without constant input or interaction.

EXPLORE BASAL-IQ

Remote Software Updates

The t:slim X2 insulin pump is the first Health Canada-approved insulin pump capable of remote feature updates.‡ Using a personal computer, patients can keep their pump up to date with the latest technology during its warranty period. Eligible t:slim X2 insulin pump users have access to future features and predictive technologies without having to purchase new device hardware.

Supplies

We offer a variety of infusion sets to give our Tandem Diabetes Care® pump users a choice of cannula materials, tubing lengths, insertion angles, and insertion techniques. We also provide access to supplementary instructional videos on the Tandem Diabetes Care patient website.

Request to be Contacted

If you are a clinician and want to learn more about our products, please fill out this form and a representative will contact you. If you are a Tandem pump user, please contact Tandem.

All form fields are required. By submitting this form, you grant Tandem Diabetes Care, Inc. permission to add your contact information to our database to send you information and communications related to our products. We respect and uphold the confidentiality of your personal information, and will not share your information with any third parties, except as noted in our privacy policy. A link to our privacy policy is available at the bottom of this page.

Responsible Use of Basal-IQ technology and Control-IQ technology

Systems like the t:slim X2 insulin pump with Basal-IQ technology and the t:slim X2 insulin pump with Control-IQ technology are not substitutes for active diabetes management. For example, users still must bolus for meals. Basal-IQ technology is designed to predict and help prevent lows, but it cannot prevent all lows and Basal-IQ technology does not predict high glucose events. Control-IQ technology is designed to predict and help prevent low and high glucose events, but it cannot prevent all highs and lows, and Control-IQ requires that users accurately input information, such as meals and periods of sleep or exercise. The Basal-IQ and Control-IQ features rely on continuous CGM readings and will not be able to predict glucose levels and adjust insulin dosing if the CGM is not working properly or is unable to communicate with the pump. Users must be sure to always use their pump, cartridges, CGM, and infusion sets as instructed and check them regularly to make sure they are working properly. Users should always pay attention to their symptoms, actively monitor and manage glucose levels, and treat according to prescriber recommendations.

* As measured by CGM. Dexcom G6 CGM sold separately.
† If glucose values are predicted to be above 10 mmol/L, Control-IQ technology calculates a correction bolus with a target of 110 mg/dL and delivers 60% of that value. It will do this up to once per hour as needed.
‡ Additional feature updates are not currently available for the t:slim X2 insulin pump with Control-IQ technology and are subject to Health Canada approvals. Additional training may be required to access certain future software updates. Software updates are only available to customers who are in warranty at the time they update their pump. Charges may apply. Future updates for all or some of Tandem's products may not be developed and may not be offered everywhere. Tandem may discontinue select software and features over time at its discretion

References:
1. 38% smaller than MiniMed 630G and 670G and at least 28% smaller than MiniMed 530G, Animas Vibe, and Omnipod System. Data on file, Tandem Diabetes Care.
2. Forlenza GP, Li Z, Buckingham BA, et al. Predictive low-glucose suspend reduces hypoglycemia in adults, adolescents, and children with type 1 diabetes in an at-home randomized crossover study: Results of the PROLOG trial. Diabetes Care. 2018;41(10):2155-2161. doi: 10.2337/dc18-0771.

Important Safety Information

The pump and each System below is indicated for use in individuals six years of age and greater. The pump and each System is intended for single user use. The pump and each System is indicated for use with NovoRapid, Admelog, or Humalog U-100 insulin.

The t:slim X2 insulin pump with Basal-IQ technology (the Basal-IQ System) consists of the t:slim X2 insulin pump, which contains Basal-IQ technology, and a compatible continuous glucose monitor (CGM, sold separately). The t:slim X2 insulin pump is intended for the subcutaneous delivery of insulin, at set and variable rates, for the management of diabetes mellitus in people requiring insulin. The t:slim X2 insulin pump can be used solely for continuous insulin delivery and as part of the Basal-IQ System. When used with a compatible CGM, the t:slim X2 insulin pump with Basal-IQ technology can be used to suspend insulin delivery based on CGM sensor readings.

The t:slim X2 insulin pump with Control-IQ technology (the Control-IQ System) consists of the t:slim X2 insulin pump, which contains Control-IQ technology, and a compatible continuous glucose monitor (CGM, sold separately). The t:slim X2 insulin pump is intended for the subcutaneous delivery of insulin, at set and variable rates, for the management of diabetes mellitus in people requiring insulin. The t:slim X2 insulin pump can be used solely for continuous insulin delivery and as part of the Control-IQ System. When used with a compatible CGM, the t:slim X2 insulin pump with Control-IQ technology can be used to automatically increase, decrease, and suspend delivery of basal insulin based on CGM sensor readings and predicted glucose values. The t:slim X2 insulin pump with Control-IQ technology can also deliver correction boluses when the glucose value is predicted to exceed a predefined threshold. The t:slim X2 insulin pump with Control-IQ technology is intended for the management of Type 1 diabetes.

Warnings:

WARNING: Control-IQ technology should not be used by anyone under the age of six years old. It should also not be used in users who require less than 10 units of insulin per day or who weigh less than 25 kilograms.

 
Do not use the t:slim X2 insulin pump with Control-IQ technology if using hydroxyurea. Neither System is indicated for use in pregnant women, people on dialysis, or critically ill users. Users of the pump and either System must: be willing and able to use the insulin pump, CGM, and all other system components in accordance with their respective instructions for use; test blood glucose levels as recommended by their healthcare provider; demonstrate adequate carb-counting skills; maintain sufficient diabetes self-care skills; see healthcare provider(s) regularly; and have adequate vision and/or hearing to recognize all functions of the pump, including alerts. The t:slim X2 pump and the CGM transmitter and sensor must be removed before MRI, CT, or diathermy treatment. Visit tandemdiabetes.com/safetyinfo for additional important safety information.